Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antiangiogenic drug to treat cancer, arthritis and retinopathy

Antiangiogenic drug to treat cancer, arthritis and retinopathy

US Patent 5932545 · Granted Aug 3, 1999

Estimated economic value: $55,582,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for 2022
Nanocarriers having surface conjugated peptides and uses thereof for sustained l2021
Nanocarriers having surface conjugated peptides and uses thereof for sustained l2020
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for 2018
Methods and compositions for inhibiting angiogenesis2010
Methods and compositions for inhibiting angiogenesis2010
Sulfonamides having antiangiogenic and anticancer activity2009
Pharmaceutical formulation comprising a peptide angiogenesis inhibitor2008
Methods and compositions for inhibiting angiogenesis2006
Methods and compositions for inhibiting angiogenesis2006
3-Amino-2-hydroxyalkanoic acids and their prodrugs2006
Methods and compositions for inhibiting angiogenesis2005